Navigating the New Landscape of Telehealth and Patient Autonomy

This chapter explores the significant shifts in telehealth and controlled substance prescribing after the pandemic, focusing on increased access and the Adderall shortage. It highlights patient reactions to new DEA regulations and emphasizes the importance of maintaining remote access to medications.